The incidence and prevalence of Crohn's disease (CD) is rising globally. Patients with moderate to severe CD are at high risk for needing surgery and hospitalization and for developing disease-related complications, corticosteroid dependence, and serious infections. Optimal management of outpatients with...
Mack, David R;
Benchimol, Eric I;
Critch, Jeff;
de Bruyn, Jennifer;
Tse, Frances;
Moayyedi, Paul;
Church, Peter;
Deslandres, Colette;
El-Matary, Wael;
Huynh, Hien;
Jantchou, Prévost;
Lawrence, Sally;
Otley, Anthony;
Sherlock, Mary;
Walters, Thomas;
Kappelman, Michael D;
Sadowski, Dan;
Marshall, John K;
Griffiths, Anne.
We aim to provide guidance for medical treatment of luminal Crohn’s disease in children. We performed a systematic search of publication databases to identify studies of medical management of pediatric Crohn’s disease. Quality of evidence and strength of recommendations were rated according to the G...
Nguyen, GC;
Seow, CH;
Maxwell, C;
Huang, V;
Leung, Y;
Jones, J;
Leontiadis, GI;
Tse, F;
Mahadevan, U;
van der Woude, CJ.
"BACKGROUND & AIMS:
The management of inflammatory bowel disease (IBD) poses a particular challenge during pregnancy because the health of both the mother and the fetus must be considered.
METHODS:
A systematic literature search identified studies on the management of IBD during pregnancy. The quality o...
Inmunosupresores/administración & dosificación,
Colitis Ulcerosa,
Enfermedad de Crohn,
Sustitución de Medicamentos,
Gastroenterología,
Servicios de Salud Materna,
Atención Preconceptiva,
Complicaciones del Embarazo,
Medición de Riesgo,
Factores de Riesgo,
Resultado del Tratamiento,
Enfermedades Inflamatorias del Intestino,
Enfermedad de Crohn/diagnóstico,
Enfermedad de Crohn/terapia,
Complicaciones del Embarazo/diagnóstico,
Complicaciones del Embarazo/terapia,
Inmunosupresores/efectos adversos,
Colitis Ulcerosa/diagnóstico,
Colitis Ulcerosa/terapia
This article has an accompanying continuing medical education activity on page e17. Learning Objective: Upon completion of this test, successful learners will be able to: (1) learn first-line treatment for the induction of remission in microscopic colitis; (2) identify the expected clinical benefi ts and...
Bressler, B;
Marshall, J. K;
Bernstein, C. N;
Bitton, A;
Jones, J;
Leontiadis, G. I;
Panaccione, R;
Steinhart, A. H;
Tse, F;
Feagan, B.
BACKGROUND & AIMS:: The medical management of ulcerative colitis (UC) has improved through the development of new therapies and novel approaches that optimize existing drugs. Previous Canadian consensus guidelines addressed the management of severe UC in the hospitalized patient. We now present consensu...
Factor de Necrosis Tumoral alfa,
Mercaptopurina,
Azatioprina,
Metotrexato,
Enfermedad de Crohn,
Gastroenterología,
Mercaptopurina/uso terapéutico,
Metotrexato/uso terapéutico,
Inducción de Remisión,
Enfermedad de Crohn/tratamiento farmacológico,
Factor de Necrosis Tumoral alfa/antagonistas & inhibidores